Pfizer (PFE) Pullback Creates Compelling Entry Point, Piper Jaffray Says
Tweet Send to a Friend
Piper Jaffray analyst Richard Purkiss reiterated an Overweight rating and $48 price target on Pfizer (NYSE: PFE) saying the recent ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
